Avidian Wealth Enterprises’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,008
Closed -$234K 504
2024
Q2
$234K Buy
1,008
+78
+8% +$17K 0.01% 449
2024
Q1
$201K Sell
930
-457
-33% -$107K 0.01% 428
2023
Q4
$359K Buy
1,387
+75
+6% +$18.4K 0.02% 313
2023
Q3
$337K Sell
1,312
-2,092
-61% -$560K 0.02% 311
2023
Q2
$970K Buy
3,404
+41
+1% +$12.2K 0.06% 182
2023
Q1
$935K Sell
3,363
-29
-0.9% -$8.02K 0.05% 209
2022
Q4
$939K Sell
3,392
-528
-13% -$149K 0.06% 187
2022
Q3
$1.05M Buy
3,920
+937
+31% +$199K 0.08% 143
2022
Q2
$608K Buy
2,983
+358
+14% +$73.2K 0.04% 237
2022
Q1
$553K Buy
2,625
+660
+34% +$144K 0.03% 281
2021
Q4
$471K Buy
1,965
+17
+0.9% +$4.37K 0.03% 315
2021
Q3
$551K Buy
1,948
+392
+25% +$128K 0.04% 201
2021
Q2
$539K Buy
1,556
+155
+11% +$47K 0.04% 207
2021
Q1
$392K Buy
1,401
+86
+7% +$23.2K 0.03% 245
2020
Q4
$322K Buy
+1,315
New +$339K 0.03% 248

Other funds holding BIIB